Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
- PMID: 33999547
- DOI: 10.1056/NEJMoa2101897
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
Abstract
Background: Surgical occlusion of the left atrial appendage has been hypothesized to prevent ischemic stroke in patients with atrial fibrillation, but this has not been proved. The procedure can be performed during cardiac surgery undertaken for other reasons.
Methods: We conducted a multicenter, randomized trial involving participants with atrial fibrillation and a CHA2DS2-VASc score of at least 2 (on a scale from 0 to 9, with higher scores indicating greater risk of stroke) who were scheduled to undergo cardiac surgery for another indication. The participants were randomly assigned to undergo or not undergo occlusion of the left atrial appendage during surgery; all the participants were expected to receive usual care, including oral anticoagulation, during follow-up. The primary outcome was the occurrence of ischemic stroke (including transient ischemic attack with positive neuroimaging) or systemic embolism. The participants, research personnel, and primary care physicians (other than the surgeons) were unaware of the trial-group assignments.
Results: The primary analysis population included 2379 participants in the occlusion group and 2391 in the no-occlusion group, with a mean age of 71 years and a mean CHA2DS2-VASc score of 4.2. The participants were followed for a mean of 3.8 years. A total of 92.1% of the participants received the assigned procedure, and at 3 years, 76.8% of the participants continued to receive oral anticoagulation. Stroke or systemic embolism occurred in 114 participants (4.8%) in the occlusion group and in 168 (7.0%) in the no-occlusion group (hazard ratio, 0.67; 95% confidence interval, 0.53 to 0.85; P = 0.001). The incidence of perioperative bleeding, heart failure, or death did not differ significantly between the trial groups.
Conclusions: Among participants with atrial fibrillation who had undergone cardiac surgery, most of whom continued to receive ongoing antithrombotic therapy, the risk of ischemic stroke or systemic embolism was lower with concomitant left atrial appendage occlusion performed during the surgery than without it. (Funded by the Canadian Institutes of Health Research and others; LAAOS III ClinicalTrials.gov number, NCT01561651.).
Copyright © 2021 Massachusetts Medical Society.
Comment in
-
The Closing Argument for Surgical Left Atrial Appendage Occlusion.N Engl J Med. 2021 Jun 3;384(22):2154-2155. doi: 10.1056/NEJMe2106069. Epub 2021 May 15. N Engl J Med. 2021. PMID: 33999543 No abstract available.
-
LAAO during cardiac surgery prevents stroke.Nat Rev Cardiol. 2021 Aug;18(8):543. doi: 10.1038/s41569-021-00572-x. Nat Rev Cardiol. 2021. PMID: 34045729 No abstract available.
-
Patients with Atrial Fibrillation Undergoing Cardiac Surgery: No Left Atrial Appendage Shall Remain Untouched.Innovations (Phila). 2021 Jul-Aug;16(4):301-302. doi: 10.1177/15569845211032139. Epub 2021 Aug 1. Innovations (Phila). 2021. PMID: 34338069
-
Occluding to prevent occlusion.Eur Heart J. 2021 Sep 7;42(34):3224-3225. doi: 10.1093/eurheartj/ehab464. Eur Heart J. 2021. PMID: 34492686 No abstract available.
-
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke.N Engl J Med. 2021 Sep 9;385(11):1053. doi: 10.1056/NEJMc2111008. N Engl J Med. 2021. PMID: 34496182 No abstract available.
-
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke.N Engl J Med. 2021 Sep 9;385(11):1053. doi: 10.1056/NEJMc2111008. N Engl J Med. 2021. PMID: 34496183 No abstract available.
-
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke.N Engl J Med. 2021 Sep 9;385(11):1054. doi: 10.1056/NEJMc2111008. N Engl J Med. 2021. PMID: 34496184 No abstract available.
-
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke.N Engl J Med. 2021 Sep 9;385(11):1054. doi: 10.1056/NEJMc2111008. N Engl J Med. 2021. PMID: 34496185 No abstract available.
-
Bei VHF: Vorhofohrverschluss en passant.MMW Fortschr Med. 2022 Jan;164(1):28. doi: 10.1007/s15006-022-0700-y. MMW Fortschr Med. 2022. PMID: 35043322 Review. German. No abstract available.
-
Was macht der Zahn in der Nasenhöhle?MMW Fortschr Med. 2022 Jan;164(1):28. doi: 10.1007/s15006-022-0699-0. MMW Fortschr Med. 2022. PMID: 35043323 Review. German. No abstract available.
-
Contemporary left atrial appendage management during adult cardiac surgery.J Thorac Cardiovasc Surg. 2023 Apr;165(4):1398-1404. doi: 10.1016/j.jtcvs.2022.02.029. Epub 2022 Feb 24. J Thorac Cardiovasc Surg. 2023. PMID: 35307219 No abstract available.
Similar articles
-
Concomitant Surgical Left Atrial Appendage Occlusion: a Review.Curr Cardiol Rep. 2022 Jul;24(7):823-828. doi: 10.1007/s11886-022-01705-5. Epub 2022 Apr 30. Curr Cardiol Rep. 2022. PMID: 35488947 Review.
-
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e006841. doi: 10.1161/CIRCEP.118.006841. Circ Arrhythm Electrophysiol. 2019. PMID: 30939908
-
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029. J Am Coll Cardiol. 2014. PMID: 24998121 Clinical Trial.
-
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.J Am Coll Cardiol. 2020 Jun 30;75(25):3122-3135. doi: 10.1016/j.jacc.2020.04.067. J Am Coll Cardiol. 2020. PMID: 32586585 Clinical Trial.
-
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23. Rev Neurol (Paris). 2015. PMID: 25912470 Review.
Cited by
-
Percutaneous or surgical LAAO for stroke prevention in patients with atrial fibrillation: A network meta-analysis.Heliyon. 2024 Sep 14;10(18):e37730. doi: 10.1016/j.heliyon.2024.e37730. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39323850 Free PMC article.
-
Percutaneous Left Atrial Appendage Occlusion Therapy: Evolution and Growing Evidence.Rev Cardiovasc Med. 2023 Jul 19;24(7):211. doi: 10.31083/j.rcm2407211. eCollection 2023 Jul. Rev Cardiovasc Med. 2023. PMID: 39077005 Free PMC article. Review.
-
Different Techniques of Surgical Left Atrial Appendage Closure and Their Efficacy: A Systematic Review.Rev Cardiovasc Med. 2023 Jun 27;24(6):184. doi: 10.31083/j.rcm2406184. eCollection 2023 Jun. Rev Cardiovasc Med. 2023. PMID: 39077542 Free PMC article.
-
Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives.Biomedicines. 2022 Sep 13;10(9):2268. doi: 10.3390/biomedicines10092268. Biomedicines. 2022. PMID: 36140368 Free PMC article. Review.
-
Percutaneous Left Atrial Appendage Closure With a Novel LAA Occluder for Stroke Prevention in Atrial Fibrillation.JACC Asia. 2022 Sep 6;2(5):547-556. doi: 10.1016/j.jacasi.2022.04.009. eCollection 2022 Oct. JACC Asia. 2022. PMID: 36518725 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical